EVMN
Evommune, Inc.stockNYSE
Market OpenNov 19, 2026 9:47:50 AM EST
7.00USD+1.449%(+0.10)21,227
EVMN Financials
In Q3 FY 2026 (ended ), Evommune, Inc. (EVMN) reported revenue of $0, net income of −$30.88M, operating cash flow of −$25.88M, and assets of $278.3M (filed ).
Loading financial statements…